Trends in the Aesthetic Biotech Market In 1978, scientists isolated human insulin produced by genetically modified E. coli, marking the first biopharmaceutical derived from recombinant DNA technology. This radically new methodology for isolating enzymes and active ingredients shook biotechnology to the core, triggering a tsunami of discoveries. …

Going Public through Shell Companies in the US and Canada What is a shell company? In recent years, shell companies have gained traction on Wall Street in the form of SPACs or “special purpose acquisition companies.” Shell companies such as SPACs are companies with no commercial operations or staff. Instead…

Advances in the collective genetic understanding of diseases, and the ability to identify disease biomarkers, is ushering in a new era of personalized medicine. Technologies such as CRISPR/Cas9 are also paving the way for improved, more tailored treatments targeted to a specific genetic marker of a disease. …

At the beginning of the pandemic, the world was forced to adapt to a “new normal” in which in-person shopping was halted in favor of online retail to reduce the spread of COVID-19. As a result, brick-and-mortar stores suffered, and some even closed for a period of time in the…

In recent years, biomedical research on topics surrounding longevity and aging has gained a tremendous amount of traction. The biotech industry as well as major pharmaceutical companies, have also jumped onto the bandwagon of discovering ways to alter and reverse the aging process. Currently, the business of anti-aging is valued…

The COVID-19 pandemic has forced companies to adapt quickly to thrive in the face of changing threats. Businesses have learned a lot about the value of remaining adaptable in the short-term, that is, throughout the pandemic. However, the pandemic has revealed a need for a longer-term approach to business that…

Do you believe you are, or can be, a successful day trader, buying and selling stocks on a regular basis? Do you believe that you, or anyone you know, can successfully time the market, going in and out of the market, and consistently make profits? You can’t, or at least…

Tech and healthcare are working together in the COVID-19 pandemic to benefit the greater good. That’s why CNBC has predicted that both industries, including biopharma and biotech, will make gains in 2021. COVID-19 has put biopharma in the limelight and big-name tech investors are moving in: for example, tech entrepreneur…